10/11
12:21 pm
fold
Rating for FOLD
Low
Report
Rating for FOLD
10/11
12:21 pm
fold
Rating for FOLD
Low
Report
Rating for FOLD
9/20
12:19 pm
fold
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
Medium
Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
9/20
12:14 pm
fold
Rating for FOLD
Medium
Report
Rating for FOLD
9/6
08:04 am
fold
Rating for FOLD
Low
Report
Rating for FOLD
9/6
08:04 am
fold
Rating for FOLD
Low
Report
Rating for FOLD
8/16
08:06 am
fold
Rating for FOLD
Low
Report
Rating for FOLD
8/9
08:21 am
fold
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
8/9
05:32 am
fold
Rating for FOLD
Low
Report
Rating for FOLD
8/9
05:32 am
fold
Rating for FOLD
Low
Report
Rating for FOLD